Evidence map›Paper›PMID 31423758›Full record

ArticleMolecular genetics & genomic medicine2019

Seven novel mutations of ADAR in multi-ethnic pedigrees with dyschromatosis symmetrica hereditaria in China.

Peng Wang, Shirong Yu, Jianyong Liu, Dezhi Zhang, Xiaojing Kang

Registry-linked trialOpen access · goldAbstract read
In one paragraph

Article in Molecular genetics & genomic medicine, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT05603819 (Clinical Validation Study for EDIT-B Test), which is not on this map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
0.4field-weighted citation impact, top 38% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT05603819 completednot on this mapstarted 2022, after this paper: background citation

Clinical Validation Study for EDIT-B Test: an Aid for Differential Diagnosis of Bipolar Disorder, Based on RNA Editing Blood Biomarkers

TypeobservationalSponsorAlcediagRan2022 to 2024Enrolled418ConditionsBipolar Disorder, Major Depressive DisorderArmsEDIT-B
3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 11 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Lung involvement in monogenic interferonopathies.European respiratory review : an official journal of the European Respiratory Society · 2020
    Article
  8. Review
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Peng WangDepartment of Dermatology, People's Hospital of Xinjiang Uygur Autonomous Region, Urumqi, China.ORCID 0000-0002-4757-8737
Shirong YuDepartment of Dermatology, People's Hospital of Xinjiang Uygur Autonomous Region, Urumqi, China.
Jianyong LiuDepartment of Dermatology, People's Hospital of Xinjiang Uygur Autonomous Region, Urumqi, China.
Dezhi ZhangDepartment of Dermatology, People's Hospital of Xinjiang Uygur Autonomous Region, Urumqi, China.
Xiaojing KangDepartment of Dermatology, People's Hospital of Xinjiang Uygur Autonomous Region, Urumqi, China.
People's Hospital of Xinjiang Uygur Autonomous Region · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundDyschromatosis symmetrica hereditaria (DSH;OMIM: #127400) is a rare autosomal dominant skin disease of hyperpigmented and hypopigmented macules on the dorsal aspects of the feet and hands. The adenosine deaminase RNA-Specific (ADAR;OMIM: *146920) gene was identified as causing DSH. Although more than 200 mutations are reported, no research has included the pedigrees of ethnic minorities in China. To investigate clinical features and genetic factors among multi-ethnic families, seven multi-ethnic pedigrees with DSH were collected for analysis of hereditary characteristics and ADAR mutations.

methodsAll 15 exons and exon-intron sequences of the ADAR gene were amplified and Sanger sequenced from 25 patients and 36 normal controls from seven multi-ethnic DSH families with 100 healthy normal controls. Seven mutations were analyzed by Polyphen 2, SIFT and Provean. All mutations in ADAR with DSH were reviewed and genetic and clinical features were summarized for analysis. The ADEAMc domain may be a hot spot of ADAR mutations among patients with DSH.

resultsSeven novel mutations were identified in seven multi-ethnic pedigrees: c.497delA(p.Arg105fs), c.3352C>T(p.Gln1058*) and c.3722delT(p.Ser1181fs) were found in three Uygur families with DSH; c.1330A>G(p.Val332Met) and c.2702A>T(p.His841Leu) were found in two Kazakh pedigrees and c.1176G>A(p.Lys326Glu) and c.2861G>A(p.Arg892His) in two Hui pedigrees. We summarized 203 different mutations of ADAR from people with DSH.

conclusionsSeven novel mutations were identified in seven multi-ethnic families with DSH. Our study expands the genetic spectrum of ADAR mutations in DSH.

Indexed as

Adenosine DeaminaseAsian PeopleChinaCodon, NonsenseDNA Mutational AnalysisEthnicityExonsFemaleFrameshift MutationHumansMaleMutation, MissensePedigreePhenotypePigmentation DisordersRNA-Binding ProteinsADAR protein, humanAdenosine DeaminaseCodon, NonsenseRNA-Binding Proteinsadenosine deaminase acting on RNAChinadyschromatosis symmetrica hereditariamutation

Identifiers

PMID31423758
PMCPMC6785447
OpenAlexW2969837811

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.